Poorly differentiated neuroendocrine cell carcinoma of the rectum: report of a case and literal review
- PMID: 16953071
- DOI: 10.2152/jmi.53.317
Poorly differentiated neuroendocrine cell carcinoma of the rectum: report of a case and literal review
Abstract
A 56-year-old man was admitted to our hospital because of anal bleeding. Colonoscopy and barium enema revealed type 4 tumor in the rectum. Biopsy revealed poorly differentiated adenocarcinoma. Low anterior resection with total mesorectal excision and lymph node dissection was performed. In immunohistochemical staining, chromogranin A and synaptophysin were positive at major lesion, and CEA were focal positive. The resected tumor was diagnosed pathologically as neuroendocrine cell carcinoma. The Ki-67 labeling index (LI) was 87.8%, so proliferative activity and potential malignancy was very high. Multiple metastatic tumors appeared in pelvis and lung eight months after operation. Treatment for neuroendocrine cell carcinoma of the rectum was controversial. Surgical resection and adjuvant chemotherapy might be one of the methods for gastrointestinal neruroendocrine cell carcinoma.
Similar articles
-
[Two cases of neuroendocrine carcinoma of the rectum].Gan To Kagaku Ryoho. 2011 Nov;38(12):2265-7. Gan To Kagaku Ryoho. 2011. PMID: 22202350 Japanese.
-
[A case of large cell neuroendocrine carcinoma of the rectum].Nihon Shokakibyo Gakkai Zasshi. 2015 Apr;112(4):683-9. doi: 10.11405/nisshoshi.112.683. Nihon Shokakibyo Gakkai Zasshi. 2015. PMID: 25843456 Japanese.
-
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.BMC Cancer. 2019 Oct 16;19(1):960. doi: 10.1186/s12885-019-6214-z. BMC Cancer. 2019. PMID: 31619203 Free PMC article.
-
[Long-Term Survival of a Patient with Rectal Neuroendocrine Carcinoma after Treatment with Curative Resection and Adjuvant Chemotherapy with Capecitabine].Gan To Kagaku Ryoho. 2015 Dec;42(13):2485-8. Gan To Kagaku Ryoho. 2015. PMID: 26809310 Review. Japanese.
-
Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the rectum.Clin J Gastroenterol. 2025 Apr;18(2):324-329. doi: 10.1007/s12328-025-02099-x. Epub 2025 Feb 10. Clin J Gastroenterol. 2025. PMID: 39928286 Review.
Cited by
-
Cutaneous metastasis of neuroendocrine carcinoma.Indian J Dermatol. 2013 May;58(3):247. doi: 10.4103/0019-5154.110890. Indian J Dermatol. 2013. PMID: 23723522 Free PMC article. No abstract available.
-
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report.Surg Case Rep. 2024 Sep 19;10(1):220. doi: 10.1186/s40792-024-02010-9. Surg Case Rep. 2024. PMID: 39294428 Free PMC article.
-
Comparative analysis of colorectal mixed adenoneuroendocrine carcinoma and adenocarcinoma with neuroendocrine differentiation: a population-based study.Int J Clin Exp Pathol. 2019 Mar 1;12(3):922-932. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933902 Free PMC article.
-
Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Colon-a Rare Differential Diagnosis of Malignant Colon Tumours.J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S211-4. doi: 10.1007/s12029-012-9372-7. J Gastrointest Cancer. 2012. PMID: 22392086 No abstract available.
-
Large Friable Rectal Neuroendocrine Tumor Complicated by Hemorrhagic Shock: A Rare Case Report and Review of the Literature.JGH Open. 2025 Feb 4;9(2):e70112. doi: 10.1002/jgh3.70112. eCollection 2025 Feb. JGH Open. 2025. PMID: 39911296 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials